Gene · 25978
Papers1,597
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 1,597
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The potential for the use of leghemoglobin and plant ferritin as sources of iron. | Open Life Sci | 2023 | 38152583 | PubTator, text mining | PubMed |
| An Inducible ESCRT-III Inhibition Tool to Control HIV-1 Budding. | Viruses | 2023 | 38140530 | PubTator, text mining | PubMed |
| Transcriptome Analysis Reveals the Involvement of Mitophagy and Peroxisome in the Resistance to QoIs in Corynespora cassiicola. | Microorganisms | 2023 | 38137993 | PubTator, text mining | PubMed |
| Pyroptosis-related gene signature: A predictor for overall survival, immunotherapy response, and chemosensitivity in patients with pancreatic adenocarcinoma. | Heliyon | 2023 | 38125471 | PubTator, text mining | PubMed |
| Integrated analysis of bulk RNA-seq and single-cell RNA-seq reveals the function of pyrocytosis in the pathogenesis of abdominal aortic aneurysm. | Aging (Albany NY) | 2023 | 38112597 | PubTator, text mining | PubMed |
| Exploring epigenetic drift and rare epivariations in amyotrophic lateral sclerosis by epigenome-wide association study. | Front Aging Neurosci | 2023 | 38090719 | PubTator, text mining | PubMed |
| Selective cargo sorting in stem cell-derived small extracellular vesicles: impact on therapeutic efficacy for intervertebral disc degeneration. | Clin Transl Med | 2023 | 38037469 | PubTator, text mining | PubMed |
| Mechanisms and Optimization Strategies of Paracrine Exosomes from Mesenchymal Stem Cells in Ischemic Heart Disease. | Stem Cells Int | 2023 | 38034060 | PubTator, text mining | PubMed |
| Endosomal Arl4A attenuates EGFR degradation by binding to the ESCRT-II component VPS36. | Nat Commun | 2023 | 38030597 | PubTator, text mining | PubMed |
| Targeted down-regulation of SRSF1 exerts anti-cancer activity in OSCC through impairing lysosomal function and autophagy. | iScience | 2023 | 38025785 | PubTator, text mining | PubMed |
| A pyroptosis gene-based prognostic model for predicting survival in low-grade glioma. | PeerJ | 2023 | 38025749 | PubTator, text mining | PubMed |
| Alterations of lipid-related genes during anti-tuberculosis treatment: insights into host immune responses and potential transcriptional biomarkers. | Front Immunol | 2023 | 38022579 | PubTator, text mining | PubMed |
| (L)-Monomethyl Tyrosine (Mmt): New Synthetic Strategy via Bulky 'Forced-Traceless' Regioselective Pd-Catalyzed C(sp2)-H Activation. | Pharmaceuticals (Basel) | 2023 | 38004457 | PubTator, text mining | PubMed |
| Pharmacogenomics of Dementia: Personalizing the Treatment of Cognitive and Neuropsychiatric Symptoms. | Genes (Basel) | 2023 | 38002991 | PubTator, text mining | PubMed |
| Targeting ferroptosis in melanoma: cancer therapeutics. | Cell Commun Signal | 2023 | 37996827 | PubTator, text mining | PubMed |
| Microautophagy regulated by STK38 and GABARAPs is essential to repair lysosomes and prevent aging. | EMBO Rep | 2023 | 37987447 | PubTator, text mining | PubMed |
| mTOR inhibition suppresses salinomycin-induced ferroptosis in breast cancer stem cells by ironing out mitochondrial dysfunctions. | Cell Death Dis | 2023 | 37968262 | PubTator, text mining | PubMed |
| Harnessing Ferroptosis to Overcome Drug Resistance in Colorectal Cancer: Promising Therapeutic Approaches. | Cancers (Basel) | 2023 | 37958383 | PubTator, text mining | PubMed |
| Peptide-based approaches to directly target alpha-synuclein in Parkinson's disease. | Mol Neurodegener | 2023 | 37940962 | PubTator, text mining | PubMed |
| Shared and Unique Disease Pathways in Amyotrophic Lateral Sclerosis and Parkinson's Disease Unveiled in Peripheral Blood Mononuclear Cells. | ACS Chem Neurosci | 2023 | 37939393 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/25978/papers?page=6